Podcasts about surgical director

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning speaks with Dr. Mario Castillo-Sang, the Surgical Director of Mitral Valve and Heart Failure Therapies at St. Elizabeth Healthcare, Edgewood, Kentucky, USA, about totally endoscopic cardiac surgery. Chapters 00:00 Intro 01:17 Minimal Access Bedside Cardiac 04:37 Lung Cancer, Histological Subtype 09:29 TAVR vs SAVR, AS & CAD 12:22 Biopros TVR Outcomes 15:48 Mitral Annular Disjunction, MVR 18:47 Ozaki Technique, AV Reconst 20:46 Redo LVOT Reconst for Endocarditis 22:33 Totally Endoscopic ASD Closure TVR 24:08 Dr. Castillo-Sang, MI Bedside Endoscopy 40:51 Closing They explore key highlights from Dr. Castillo-Sang's CTSNet series Endoscopic Cardiac Surgery Series: The Swiss Army Knife Approach, his journey in performing endoscopic surgeries, and how he learned the techniques. Dr. Castillo-Sang shares the advantages of endoscopic surgery, as well as tips and recommendations for those wanting to learn this approach. He emphasizes the importance of the instruments he has worked with, detailing how these have improved over time. Additionally, they explore Dr. Castillo-Sang's involvement with the Endoscopic Cardiac Surgeons Club, discussing how he got involved and providing details about the club's upcoming annual meeting.   Joel also highlights recent JANS articles on the estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time, transcatheter vs surgical aortic valve replacement in Medicare beneficiaries with aortic stenosis and coronary artery disease, long-term outcomes after bioprosthetic tricuspid valve replacement, and outcomes of patients with mitral annular disjunction undergoing mitral valve repair.  In addition, Joel explores aortic valve reconstruction using the Ozaki technique, redo LVOT reconstruction for endocarditis, and totally endoscopic ASD closure with tricuspid valve repair. Before closing, he highlights upcoming events in CT surgery.   JANS Items Mentioned  1.) Estimated Worldwide Variation and Trends in Incidence of Lung Cancer by Histological Subtype in 2022 and Over Time: A Population-Based Study  2.) Transcatheter vs Surgical Aortic Valve Replacement in Medicare Beneficiaries With Aortic Stenosis and Coronary Artery Disease  3.) Long-Term Outcomes After Bioprosthetic Tricuspid Valve Replacement: A Multicenter Study  4.) Outcomes of Patients With Mitral Annular Disjunction Undergoing Mitral Valve Repair  CTSNET Content Mentioned  1.) Aortic Valve Reconstruction—The Ozaki Technique  2.) Redo LVOT Reconstruction for Endocarditis  3.) Totally Endoscopic ASD Closure With Tricuspid Valve Repair  Other Items Mentioned  1.) Endoscopic Cardiac Surgery Series: The Swiss Army Knife Approach  2.) Endoscopic Cardiac Surgeons Club  3.) Mini Heart Valves   4.) Aortic Valve Replacement Series     5.) Career Center 6.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

LIVE from CHLA for the Make March Matter Campaign! We continue to get to know the real heroes of CHLA. We are now joined by Dr. Erin Meisel, Pediatric Extremity Surgeon at CHLA. More on if Greg and Travis will wake up at 3 am to watch the Dodgers? Also, we talk to and get to know Dr. Virendra Desai who is the Surgical Director of the Comprehensive Epilepsy Center at CHLA. Plus, producer Emily has her topics ready for another edition of FACT OR CAP joined by Phil from Handel's Ice Cream. Learn more about your ad choices. Visit podcastchoices.com/adchoices

What a way to kick off a new year of Full Circle! Tune in now to hear my conversation with guests from Sierra Donor Services. Joining the program today was Dr. Beau Kelly, Surgical Director. Dr. Kelly is a dedicated surgeon-researcher-teacher-leader in the field transplantation, and he's passionate about elevating the patient voice and the representation of underrepresented communities in academic medicine. Michael P. Coleman, Director of External Affairs and his team make it their mission to inform all communities of the need or organ and tissue donation, especially those in underserved areas. To learn more about Sierra Donor Services, visit their website. Give the gift of life!

Three-dimensional printing technology has been around for decades, but has seen a rapid expansion into commercial, manufacturing and industrial use over the past few years. As it makes its way into health care, what benefits could this relatively new technology offer?Dr. Kevin Chen, Chief of Pediatric Surgery at Cardinal Glennon and Surgical Director of the 3D Lab at SSM Health, joins the show to discuss the use of 3D printing in his everyday work. Dr. Chen discusses how it can be used as an educational tool, how it affects the patient-caregiver relationship and where the technology can go in the future.ResourceRead the Catholic Health World story from July 2024 covering Dr. Chen's work at the SSM Health 3D Lab

If you're an ASOPRS Member, Surgeon or Trainee and are interesting in hosting a podcast episode, please submit your idea by visiting: asoprs.memberclicks.net/podcast About the Guests: Dr. Donovan Reed: An oculoplastic surgeon serving as the Surgical Director at Wilford Hall Eye Center and Brooke Army Medical Center in San Antonio, Texas. Dr. Tanuj Nakra: Associate professor at UT Austin Dell Medical School and at Texas Oculoplastics Consultants. He also serves as the Fellowship Director for the American Academy of Cosmetic Surgery Facial Cosmetic Surgery Fellowship. Dr. Catherine Hwang: Specialist at the Cleveland Clinic Cole Eye Institute with a focus on cutting-edge oculoplastic and aesthetic surgical techniques. Dr. Daniel Rootman: Esteemed surgeon at the Doheny Eye Institute at UCLA, known for his significant research contributions in oculoplastic surgery. Episode Summary: Welcome to another exciting episode of The Oculofacial Podcast with your host, Dr. Donovan Reed. Joining him in this episode are the esteemed Drs. Tanuj Nakra, Catherine Hwang, and Daniel Rootman. This episode delves into the latest research findings from journals beyond "OPRS" relevant to cosmetic and aesthetic surgery in the field of oculofacial surgery. In this episode, the panel discusses anatomic insights from the article published in "Plastic and Reconstructive Surgery" about avoiding pretarsal denervation in lower blepharoplasty incisions. Dr. Tanuj Nakra gives an in-depth summary and sparks a discussion about the practical applications and impacts of these new findings on common surgical techniques. Moving forward, Dr. Catherine Hwang introduces a refined method for double eyelid blepharoplasty from a group in China, emphasizing its potential to reduce postoperative swelling. Dr. Daniel Rootman wraps up with a novel approach using barbed sutures for fat transposition described in "Facial Plastic Surgery and Aesthetic Medicine." Key Takeaways: New Findings on Orbicularis Innervation: The updated anatomical understanding shows the complexity and importance of the lower medial pretarsal branch, impacting lower blepharoplasty techniques. Innovative Double Eyelid Surgery: A modified technique introduces less trauma to the orbicularis muscle, aiming for rapid recovery and satisfactory outcomes in patients. Barbed Sutures for Efficiency: The single-barb suture method offers an innovative way to internalize fat pedicle fixation, though it needs careful patient selection to avoid complications like dimpling. Patient-Centric Techniques: Personalized approaches in aesthetics are crucial, with surgeons adapting techniques based on individual patient needs and anatomical nuances. Continuous Learning and Adaptation: Highlighting the importance of staying updated with the latest scientific findings to refine surgical practices and improve patient outcomes. Resources: American Academy of Cosmetic Surgery Facial Cosmetic Surgery Fellowship Plastic and Reconstructive Surgery Journal Cleveland Clinic Coal Eye Institute Doheny Eye Institute at UCLA Stay tuned for more enlightening discussions from the Oculofacial Podcast. If you found this episode insightful, make sure to listen to the full conversation and catch our next episode for even more professional insights!

Welcome to the first episode of our new collaborative series with the Association of Surgeons in Great Britain and Ireland! During this series, BTK fellow Jon Williams and ASGBI hosts Kellie Bateman and Jared Wohlgemut compare and contrast the surgeon profession between the United States and the United Kingdom, debating who does what better. In this episode, we take a deep dive into surgical training in the US and the UK, from fostering student interest to trainee operating to specialization and certification. Dr. Jeremy Lipman represents the US while Dr. Jon Lund represents the UK in this thought-provoking conversation. Dr. Lipman is a colorectal surgeon at the Cleveland Clinic and the director of graduate medical education for all training programs at the Cleveland Clinic. Additionally, he is an Associate Dean for Graduate Medical Education and Professor of Surgery at Case Western Reserve University. After going to Boston College for his bachelor degree, he obtained his medical degree from Drexel University College of Medicine in Philadelphia. Subsequently he completed his general surgery residency training at Case Western and his colorectal surgery fellowship at Cleveland Clinic. After practicing at MetroHealth Medical Center where he served many training and education leadership roles, he returned to Cleveland Clinic as faculty where he remains today. Dr. Lund is Professor and Head of the Department of Surgery at University of Nottingham at Derby, and Consultant Colorectal Surgeon at Royal Derby Hospital. He is Chair of the Joint Committee on Surgical Training, and before that was Surgical Director of the Intercollegiate Surgical Curriculum Programme, the online training management system used by all trainees and trainers in Surgery in the UK. He has recently been appointed as Dean of education at the Royal College of Surgeons of Edinburgh. So, who trains surgeons better? UK or US? Give the episode a listen and decide for yourself! Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

As surgical director of The Northwell Health Cancer Institute's new Skin Cancer Program, Bhuvanesh Singh, MD, PhD, will lead the development of multiple integrated centers that will provide state-of-the-art care, as well as clinical and translational research to help shape the future of skin cancer treatment. The new program will benefit patients with more complex skin cancers, offering single center where all needs are addressed. Read the full article Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

In this episode, we're joined by Dr. Oluwadamilola "Lola" Fayanju, a leader in breast cancer care and health equity. With a remarkable background that spans clinical excellence and innovative research, Dr. Fayanju holds the Helen O. Dickens Presidential Associate Professorship at the University of Pennsylvania (PENN) and serves as Chief of Breast Surgery at Penn Medicine. She also leads as the Surgical Director of the Rena Rowan Breast Center, directs Health Equity Innovation at the Penn Center for Cancer Care Innovation, and is a Senior Fellow at the Leonard Davis Institute of Health Economics.

In this episode, Dr. Mistry and Donna Lee are joined by another special guest this week, Dr. Buckley!  F. P. “Tripp” Buckley III, MD, is a board-certified surgeon and the Surgical Director of Digestive Health, a clinical partnership between Ascension Seton and UT Health Austin. He specializes in anti-reflux and esophageal surgery, assisting patients suffering from gastroesophageal reflux disease (GERD). Additionally, Dr. Buckley is an associate professor and serves as the Chief of the Division of Elective Surgery for the Dell Medical School Department of Surgery and Perioperative Care. Do you have the guts to learn about your gut?!? What stomach problems to you have? What does your pancreas do?  Do you need reflux surgery or just some Tums? Where exactly is your sphinter? Is a hiatal hernia too small or too large for surgery? How do you spell esophagus? Well, you must tune in to learn the answers to these thought-provoking questions.  To learn more about Dr. Buckley, visit https://uthealthaustin.org/directory/tripp-buckley and his number is (512 324-GERD, Clever!  Share this with your friends and follow us wherever you listen to podcasts! Voted top Men's Health Podcast, Sex Therapy Podcast, and Prostate Cancer Podcast by FeedSpot.Dr. Mistry is a board-certified urologist and has been treating patients in the Austin and Greater Williamson County area since he started his private practice in 2007.We enjoy hearing from you! Email us at armormenshealth@gmail.com and we'll answer your question in an upcoming episode.Phone: (512) 238-0762Email: armormenshealth@gmail.comWebsite: armormenshealth.comOur Locations:Round Rock Office970 Hester's Crossing RoadSuite 101Round Rock, TX 78681Lakeline Office12505 Hymeadow DriveSuite 2CAustin, TX 78750South Austin Office6501 South CongressSuite 1-103Austin, TX 78745Dripping Springs Office170 Benney LaneSuite 202Dripping Springs, TX 78620

On this episode of JHLT: The Podcast, the JHLT Digital Media Editors explore two studies from the July issue of The Journal of Heart and Lung Transplantation. Digital Media Editor Marty Tam, MD, a transplant cardiologist from the University of Michigan in Ann Arbor, hosts this episode.   First, Dr. Tam and Digital Media Editor Erika Lease, MD, FCCP, interview their first guest, Daniel Calabrese, MD, first author on the study “Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression.” The study's authors sought to tackle challenges behind early detection of chronic lung allograft dysfunction (CLAD) by identifying biomarkers associated with acute lung allograft dysfunction (ALAD) progression to CLAD.   To do this, they collected bronchoalveolar lavage (BAL) cells at the time of ALAD diagnosis and performed single cell RNA sequencing to identify significant differences in 26 unique cell populations across groups, with discordant CD8 T cells and macrophages providing the best discrimination between ALAD with decline from ALAD with recovery and controls.   Dr. Calabrese discusses how his team identified the diagnostic criteria, why the biomarkers might lead ALAD to progress to CLAD, and how the findings might lead to early targeted therapies.   Next, Dr. Tam joins and Digital Media Editor Khue Ton, MD and David Schibilsky, MD, to interview their next guest, David D'Alessandro, MD, the Surgical Director of Cardiac Transplantation and MCS at Massachusetts General Hospital in Boston. Dr. D'Alessandro was the first author on the study “Impact of controlled hypothermic preservation on outcomes following heart transplantation,” which sought to assess the impact of the Paragonix SherpaPak Cardiac Transport System, a device allowing controlled hypothermic  preservation, on rates of primary graft dysfunction (PGD) and post-transplant mortality.   The key finding was that controlled hypothermic preservation was associated with a lower incidence of severe PGD – 6.6% compared to ice storage at 10.4%. In the conversation, Dr. D'Alessandro answers questions about the need for innovation over traditional ice cold storage, the greatest advantages of controlled hypothermic approaches, and the next steps in this research.   Follow along at www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.   Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

The Heart Transplant Program at Lurie Children's is one of the largest and most comprehensive heart transplant programs of its kind in the country. Just a few years ago, it reached a major milestone of completing its 400th pediatric heart transplant. The program's 40-person cardiovascular thoracic surgery team makes the program uniquely equipped to handle the most high-risk cases with exceptional care. In this episode, Dr. Michael Mongé, Surgical Director of the Lurie Children's Heart Transplant Program and Dr. Philip Thrush, Medical Director of the program, discuss how their team is uniquely equipped to take on high-risk pediatric heart transplantation patients, who are often turned away at other hospitals.

On this UVA Speaks podcast, Shawn Pelletier, MD, Professor and Chief of the Division of Transplant Surgery at the University of Virginia Health System, shares with us. He explains the different aspects of organ donation from living donors who donate their kidneys or part of their liver and those who arrange to donate their organs after death. Dr. Pelletier shares medical advances that have enabled surgeons and transplant teams to provide life-saving care to more patients. The need for transplanted organs outpaces the available supply. In 2023, there were 46,000 transplants performed; however, over 103,000 patients are currently on the transplant waiting list. Transcripts of the audio broadcast can be found here. Shawn Pelletier, MD, is a Professor, Chief of the Division of Transplant Surgery, Director of the Transplant Service Line, and Surgical Director of the Liver Transplant Program at UVA Health Systems. He has been on the faculty at UVA for 12 years, is a leader in several professional organizations, and has contributed to more than 100 articles in peer-reviewed journals.

Dr. Douglas Johnston, Chief, Division of Cardiac Surgery, Surgical Director, Bluhm Cardiovascular Institute, and Dr. Baljash Singh Cheema, Advanced Heart Failure & Transplant Cardiology, Bluhm Cardiovascular Institute, join John Williams to tell us what we should know about heart failure. Dr. Johnston and Dr. Cheema explain what heart failure is, the risk factors and health […]

Dr. Douglas Johnston, Chief, Division of Cardiac Surgery, Surgical Director, Bluhm Cardiovascular Institute, and Dr. Baljash Singh Cheema, Advanced Heart Failure & Transplant Cardiology, Bluhm Cardiovascular Institute, join John Williams to tell us what we should know about heart failure. Dr. Johnston and Dr. Cheema explain what heart failure is, the risk factors and health […]

Dr. Douglas Johnston, Chief, Division of Cardiac Surgery, Surgical Director, Bluhm Cardiovascular Institute, and Dr. Baljash Singh Cheema, Advanced Heart Failure & Transplant Cardiology, Bluhm Cardiovascular Institute, join John Williams to tell us what we should know about heart failure. Dr. Johnston and Dr. Cheema explain what heart failure is, the risk factors and health […]

Dr. Albert Kim is the August A. Busch Jr. Professor of Neurological Surgery, Senior Vice-Chair of the Department of Neurosurgery, and Professor of Genetics, Neurology, and Developmental Biology at Washington University School of Medicine. He is also the inaugural Director of the Washington University Brain Tumor Center and Surgical Director of the Pituitary Center. Dr. Kim is an expert in glioblastoma, the most common and most aggressive primary brain tumor in adults. His laboratory studies the ways that glioblastoma arises as well as ways to treat it through targeting genetics, metabolism, and the immune system in addition to the use of high powered lasers to thermally ablate tumors. As one of the researchers in his lab, I can attest to Dr. Kim's true brilliance as a physician and scientist, so I hope you enjoy this episode. Title music: World Is Holding Hands by WinnieTheMoog https://creativecommons.org/licenses/by/4.0/legalcode Background music: En Plein Air by L'Esprit d'Sfign https://creativecommons.org/licenses/by-nc/4.0/legalcode.en

August 21, 2023 ~ A pancreas transplant is the least known organ transplant, and it is usually done in conjunction with a kidney transplant. Listen in as Dr. Randall Sung, the Surgical Director of Kidney and Pancreas Transplant at Michigan Medicine and Professor of Surgery at the University of Michigan School of Medicine talks about pancreas transplants, who is most at risk, and what you need to do to avoid needing one.

August 21, 2023 ~ A pancreas transplant is the least known organ transplant, and it is usually done in conjunction with a kidney transplant. Listen in as Dr. Randall Sung, the Surgical Director of Kidney and Pancreas Transplant at Michigan Medicine and Professor of Surgery at the University of Michigan School of Medicine talks about pancreas transplants, who is most at risk, and what you need to do to avoid needing one.

August 21, 2023 ~ A pancreas transplant is the least known organ transplant, and it is usually done in conjunction with a kidney transplant. Listen in as Dr. Randall Sung, the Surgical Director of Kidney and Pancreas Transplant at Michigan Medicine and Professor of Surgery at the University of Michigan School of Medicine talks about pancreas transplants, who is most at risk, and what you need to do to avoid needing one.

August 21, 2023 ~ A pancreas transplant is the least known organ transplant, and it is usually done in conjunction with a kidney transplant. Listen in as Dr. Randall Sung, the Surgical Director of Kidney and Pancreas Transplant at Michigan Medicine and Professor of Surgery at the University of Michigan School of Medicine talks about pancreas transplants, who is most at risk, and what you need to do to avoid needing one.

Inflammatory bowel disease or IBD is an umbrella term to describe chronic inflammatory disorders of the GI tract – most commonly Crohn's disease and ulcerative colitis. Medications, nutritional therapies, and lifestyle modifications are all used to control symptoms and keep patients in remission. However, sometimes surgical intervention is needed. Dr. Elizabeth Raskin is an award-winning colorectal surgeon and the Surgical Director of one of the leading IBD programs in the country – the Hoag Margolis Family IBD Program. This team-based, multidisciplinary approach to helping patients with IBD addresses the medical, nutritional, and psychosocial components to these diseases. Today we speak with Dr. Elizabeth Raskin, one of the leading colorectal surgeons in the country. We hear about her unique approach to IBD - combining nutrition, functional medicine, mental, spiritual, and emotional support for better patient outcomes. Today on The Lab Report: 3:30 Meet Dr. Raskin and hear about her dedication to healing the colon 9:30 Nutritional challenges with IBD patients 14:40 Pre-habilitation before surgery 17:05 Post-op advice for primary care clinicians 20:55 IBD prevalence 22:50 The microbiome and surgery – pre and post op support 30:20 Triggers of IBD 33:50 Personalized approach to Crohn's disease 38:00 Endurance athletics and the gut 46:45 The Fireball Additional Resources: Hoag Margolis Family IBD Program Subscribe, Rate, & Review The Lab Report Thanks for tuning in to this week's episode of The Lab Report, presented by Genova Diagnostics, with your hosts Michael Chapman and Patti Devers. If you enjoyed this episode, please hit the subscribe button and give us a rating or leave a review. Don't forget to visit our website, like us on Facebook, follow us on Twitter, Instagram, and LinkedIn. Email Patti and Michael with your most interesting and pressing questions on functional medicine: podcast@gdx.net. And, be sure to share your favorite Lab Report episodes with your friends and colleagues on social media to help others learn more about Genova and all things related to functional medicine and specialty lab testing. To find a qualified healthcare provider to connect you with Genova testing, or to access select products directly yourself, visit Genova Connect. Disclaimer: The content and information shared in The Lab Report is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in The Lab Report represent the opinions and views of Michael Chapman and Patti Devers and their guests.See omnystudio.com/listener for privacy information.

Joining us on Well Said is Dr. Jose Prince and Dr. Chethan Sathya. Dr. Prince is the Vice Chair of Surgery and the System Chief of Pediatric Surgery and Acute Care Surgery for Northwell Health, Surgeon in Chief at Cohen Children's Medical Center and a professor of Surgery and Pediatrics at the Zucker School of Medicine at Hofstra/Northwell. Dr. Sathya is a Pediatric General and Thoracic Surgeon, Associate Medical Director for Trauma and the Surgical Director for Pediatric Critical Care at Cohen Children's Medical Center, assistant professor of Surgery and Pediatrics at the Zucker School of Medicine at Hofstra/Northwell and director of the Northwell Health Gun Violence Prevention Center. They will be discussing how gun violence causes physical injury to its victims, increases strain on our health systems, and reshapes entire communities.

Join the Surgical Oncology team from UTSouthwestern and the University of Miami as they tackle a journal review covering how to choose perioperative antimicrobial prophylaxis for pancreatoduodenectomy. Listen in as they also review novel methodology and the origins of the study. Learning Objectives:  What antibiotics are you giving before your Whipple? In the group's final episode together, we review the 1st of its kind, registry linked, pragmatic surgical trial in North America. In the episode we dissect “Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy - A Randomized Clinical Trial” and discuss the practice changing findings, and the future of surgical clinical trials.  Hosts:  Adam Yopp, MD, FACS (@AdamYopp) is an Associate Professor of Surgery at the UT Southwestern Medical Center and is Chief of the Division of Surgical Oncology. He also serves as Surgical Director of the Liver Tumor Program. Caitlin Hester, MD (@CaitlinAHester) is a recent graduate of the MD Anderson Complex General Surgical Oncology fellowship and is now a new faculty member in the Division of Surgical Oncology within the Sylvester Cancer Center at the University of Miami where she specializes in surgery for cancers of the liver, pancreas, and other gastrointestinal sites.  Gilbert Murimwa, MD (@GilbertZMurimwa) is a PGY-4 Research Fellow and General Surgery Resident at the UT Southwestern Medical Center. He is studying the pancreatic tumor microenvironment and targeted therapies in the lab of Rolf Brekken within the Hamon Center for Therapeutic Oncology Research. He also does work on access to care, social determinants of health, and interventions to mitigate disparities in surgical and oncologic outcomes under the mentorship of Patricio Polanco.  Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out surgical oncology episodes here: https://behindtheknife.org/podcast-category/surgical-oncology/

Elizabeth R. Raskin, M.D., is Surgical Director of the Margolis Family Inflammatory Bowel Disease (IBD) Program within the Digestive Health Institute at Hoag. A colorectal surgeon with approximately 20 years of experience advancing state-of-the-art technologies and innovative surgical techniques, Dr. Raskin understands the importance of how medical care is delivered and provides cutting-edge, comprehensive care to provide better surgical treatment and improved patient recovery. Dr. Raskin joins the podcast to discuss digestive health, the mind-gut connection, and how to live a general healthier life. She goes into details about the importance of eating properly, getting good sleep, and how to maintain a life in balance. If you enjoy this conversation, consider joining us at USANA Live 2023 Americas and Europe Convention in Salt Lake City August 10–12. Early bird pricing for Convention ends May 31. Register today and save $100. Get curious and sign up now. Follow Dr. Raskin on Instagram and Twitter.

In this episode, we talk with Dr. James Chandler! Dr. is Vice Chair and Professor in Neurological Surgery at the Northwestern Medecine's Feinberg School of Medicine and is also the Founder and Surgical Director of the Lou and Jean Malnati Brain Tumor Institute of the Robert H. Comprehensive Cancer Center. Today, we'll discuss his path to becoming a neurosurgeon, difficult experiences in his past that have driven his passion for medicine, representation in the medical industry and so much more.

It will be a special Mother's Day for a woman with 13 grandchildren who underwent a heart transplant. Guests include Dr. Matt Danter, Surgical Director of Cardiac Transplant and Mechanical Circulatory Support.

Gabriel Aldea, MD, FACS, FACC, is a board-certified cardiothoracic surgeon, Chief of Cardiac Surgery, the William K. Edmark Professor of Cardiothoracic Surgery, and the Surgical Director of the UW Medicine Heart Institute.  Dr. Aldea is a nationally recognized leader with expertise in cardiac valve replacement and repair, management of aortic aneurysms, as well as catheter-based minimally invasive valve and aortic therapies.0:46 - Dr. Aldea's Attraction to Cardiac Surgery2:44 - More than Technicians6:10 - Surgical Subspecialization9:30 - Excelling in Complex Care Collaboration and Innovation12:05 - Three Paradigm Shifts in Surgery18:40 - TAVR Cardiac Surgeon Resistance 20:20 - Forecasting Therapies in 10 years23:00 - Creativity in Cardiac Surgery26:30 - Maintaining Quality (Mitral Valve Reference Center)30:45 - Designation to Incentivize Implementation Science38:00 - Frailty and Pre-Hab45:30 - Endocarditis & Drug Use55:00 - A Reader, Swimmer and Father of a Fellowuwheart@uw.edu

Join the Surgical Oncology team from UTSouthwestern and the University of Miami as they tackle a case of intrahepatic cholangiocarcinoma along with the data guiding current treatment paradigms. Listen in as they also review recent clinical trials changing the options available for patients with this dismal biliary tract cancer. Learning Objectives:  In this episode, we review the workup and diagnostic approach to intrahepatic cholangiocarcinoma with emphasis on the role and benefits of biopsy, lymphadenectomy, operative approach, and the current treatment strategies involving chemotherapy, immunotherapy, and targeted therapies against actionable mutations. Hosts:  Adam Yopp, MD, FACS (@AdamYopp) is an Associate Professor of Surgery at the UT Southwestern Medical Center and is Chief of the Division of Surgical Oncology. He also serves as Surgical Director of the Liver Tumor Program. Caitlin Hester, MD (@CaitlinAHester) is a recent graduate of the MD Anderson Complex General Surgical Oncology fellowship and is now a new faculty member in the Division of Surgical Oncology within the Sylvester Cancer Center at the University of Miami where she specializes in surgery for cancers of the liver, pancreas, and other gastrointestinal sites.  Gilbert Murimwa, MD (@GilbertZMurimwa) is a PGY-4 Research Fellow and General Surgery Resident at the UT Southwestern Medical Center. He is studying the pancreatic tumor microenvironment and targeted therapies in the lab of Rolf Brekken within the Hamon Center for Therapeutic Oncology Research. **Specialty team application link - https://forms.gle/DwrRcMYDaP3a3LaQA Please email hello@behindtheknife.org with any questions. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out other surgical oncology episodes here: https://behindtheknife.org/podcast-category/surgical-oncology/

Dr. Dario Englot is an Associate Professor of Neurological Surgery, Neurology, Radiology & Radiological Sciences and the Surgical Director of Epilepsy at Vanderbilt University Medical Center. Dr. Englot's clinical interests include epilepsy, neuromodulation, movement disorders, pain disorders, and general neurosurgery. He also leads an active research laboratory studying brain networks in neurological disorders using neuroimaging and electrophysiology, with a particular focus in epilepsy. Dr. Englot completed his residency at University of California and his fellowship in functional neurosurgery and epilepsy at Vanderbilt. Today we are going to be speaking with Dr. Englot about using the human brain connectome to guide epilepsy treatment.

This is the Weight and Healthcare newsletter! If you like what you are reading, please consider subscribing and/or sharing!At their base, the guidelines recommend intentional weight loss for higher-weight children via “Intensive Health Behavior and Lifestyle Training” starting as early as age two (2) with drugs as young as twelve (12) and surgeries starting as early as age thirteen (13).There is a lot to unpack here, and this will be a multi-part series but I have had a flood of requests to write about them since they came out, and I had to get very familiar with them because I presented Grand Rounds at Children's Minnesota this morning, so I thought I would get started with this first ever special edition of the newsletter so that I could get this info to you sooner and keep Saturday's newsletter from becoming a novel! I'm going to start with conflicts of interest because I believe these form the rickety scaffolding upon which the rest of these recommendations rest.When I think about conflicts of interest, I generally feel that having a conflict of interest is not proof of bias, but is certainly a red flag indicating the need for taking a deeper look. Failing to freely and openly disclose a conflict of interest, on the other hand, seems more to me like a red flag doused in gasoline and set on fire. There's a lot of the latter type of red flags in these guidelines.To address conflicts of interest, the guidelines themselves state:FINANCIAL/CONFLICT OF INTEREST DISCLOSURES: An Independent review for bias was completed by the American Academy of Pediatrics. Dr Barlow has disclosed a financial relationship with the Eunice Kennedy Shriver National Institute of Child Health and Human Development as a co-investigator.That's it. That is the only conflict of interest information provided. The same language is provided at the top of the guidelines and under the section “competing interests.” I cannot find any link to the actual review that they performed (if I missed it/you have it, please feel free to leave it in the comments!) I have to tell you that Dr. Barlow's disclosed relationship is pretty much the least of my concerns here.For example, based on their disclosure language you might not guess that, of the 14 authors who are medical doctors, at least 7 have taken money from companies that are developing or sell weight loss products that either directly benefit, or may benefit from these recommendations either through the development of a new drug, or approval of an existing drug for adolescents. The amount ranged from less than $20 for food and beverage (typically indicating that the doctor had attended one or more “educational” seminars by these companies,) to one author who took more than $50,000 primarily for consulting and speaking engagements on behalf of these companies.One of the companies that many took money from was Novo Nordisk, the pharmaceutical company which is aggressively marketing the drugs that are discussed in the guidelines (with an acknowledgment that they were included in the guidelines even though the research for them was published after the evidence review had already been completed.) Also, these numbers are only for 2015-2021 and where data is available. We know that Novo Nordisk has been pouring money into their effort to promote Wegovy and make good on their promise to shareholders that they would use the drug to double their “ob*sity* sales” by 2025, so it's possible that quite a bit more money has changed hands than is represented here. Regardless, as you can see, none of these payments are mentioned in the conflict of interest statement.Based on the American Academy of Pediatrics' conflict of interest statement, you also might not guess that, in fact, Novo Nordisk is a “Patron” of the American Academy of Pediatrics itself- donating somewhere between $25,000 and $49,999 to the organization.Other “patrons” of the AAP include:GlaxoSmithKline, maker of the weight loss drug alliGenentech, which sells the weight loss drug XenicalProlacta, which manufactures human milk-based nutritional products that they claim lowers the risk of ob*sityOf course, none of this is proof that they manipulated the guidelines to benefit these companies, but absolutely none of this is disclosed in the conflict of interest statement which, again…big red flag for me. Considering all of this, I am unconvinced that the American Academy of Pediatrics was in a position to conduct an “Independent review for bias” of guidelines that are incredibly favorable for their “patrons” and the companies from which the authors received money.You may also be surprised to learn that disclosure rules don't even require that they acknowledge that almost every author has a career that is based in the “higher-weight as lifelong chronic illness” model that these guidelines embrace and perpetuate. There are authors who run pediatric weight loss clinics, authors who run pediatric weight loss surgery programs, authors who are employed as pediatric weight management specialists. Below you'll find a list of the authors with information that I pulled from their various online bios about their past and current work in pediatric “ob*sity” as well as the payments I found to them on openpayments.cms.govFor almost all of the authors, these recommendations will increase the market for their services. That doesn't necessarily mean that's why they are making the recommendations, but it's still the literal definition of a conflict of interest. And yet, no disclosure of this is even required and, as you might imagine, none is made.There is also one oddity that I want to point out. Sarah C. Armstrong (who, of the authors who are MDs, took the most money from pharmaceutical companies that do or may benefit from these guidelines at $51,050.45) claims “I subscribe to a "health at every size" approach to supporting children, teens, and young adults living with ob*sity” on the same webpage on which her title is “Medical Weight Management Specialist.” That is, quite literally, impossible as those two things are mutually exclusive. Health at Every Size™ stands completely opposed to the concept of weight management and the pathologizing of body size, including the use of the term “ob*sity.” There is no ambiguity or grey area here, Health at Every Size™ is the trademarked brand of the Association for Size Diversity and Health, there are literally rules for this. So, from my perspective either Dr. Armstrong (a medical doctor who is co-authoring guidelines for other doctors) doesn't understand the basic principles upon which she claims her practice is built, or she is co-opting the language of weight-neutral health in order to promote weight loss. Either way, to me this is concerning enough to point out.I want to be clear, I don't think that these authors are necessarily trying to create profit for themselves, or to harm children. There are a LOT of degrees and certifications held by these authors, and many hold positions at prestigious universities and healthcare facilities. I think they are probably well-intentioned and truly believe that they are doing what's best for children. (As someone who is both queer and fat, I can imagine that if, a few decades ago, you had gotten together a group of doctors who had centered their careers on treating “homosexuality,” you would have gotten guidelines very much like this.) I also think that they are deeply misguided, and that's not surprising given the billions that the weight loss industry has poured into conflating health with weight and weight loss, including in the research, and the (mis) education of healthcare practitioners. Still, I believe that, if adopted, these guidelines will do massive harm. In Saturday's regular edition of Weight and Healthcare there is a deeper dive into the guidelines themselves. And a piece specifically about their eating disorders claims is here. Here is the author list with payments and info I found about their work within the body size as pathology paradigm (note that this is not an exhaustive list and includes past and present work)Sarah E Hampl * Novo Nordisk, $15.15* Pediatrics, Weight Management Sandra G Hassink* Director of the AAP Institute for Healthy Childhood Weight* Began the weight management clinic at Nemours/AI DuPont Children's Hospital in 1988* Has collaborated in basic research efforts to identify pathophysiologic mechanisms of ob*sity* Has lectured widely in the field of pediatric ob*sity* Authored A Parent's Guide to Childhood Ob*sity, Pediatric Ob*sity: Prevention, Intervention, and Treatment Strategies for Primary Care, and Clinical Guide to Pediatric Weight Management* Dedicates a significant portion of her time to advocacy and policy development on ob*sity prevention and treatment. * Served on the IOM committee on Accelerating Progress on Ob*sity Prevention and was an author on the Expert Recommendations for Ob*sityAsheley  C Skinner* Areas of expertise: Implementation Science, Health Services Research, Child Ob*sitySarah C. Armstrong * Genetech $41,250.45, Pfizer $5,000, Novo Nordisk $4,800 * Medical Weight Management SpecialistSarah E. Barlow * Echosens $94.89, Alexion 84.31, Abbvie $52.83, Ethicon 51.10, Novo Nordisk 32.27, Avanos $14.13* Oversees an integrated program in ob*sity care that spans community programs, primary healthcare and tertiary care.Christopher F. Bolling * Allergan 145.29, Tris Pharma $50.82, GlaxoSmithKline $45.82, Sanofi $44.71, Takeda $30.39, Astra Zeneca 23.87* Ob*sity Task Force Chair, KY Chapter, American Academy of PediatricsKimberly C. Avila Edwards* Co-founded the Texas Center for the Prevention and Treatment of Childhood Ob*sity at Dell Children's Medical Center in 2010 * On the steering committee for the Institute for a Healthy Childhood Weight from 2012-2016* Chaired the Ob*sity Committee of TPS (Texas Pediatric Society) from 2007 to 2011Ihuoma Eneli* Director of the Center for Healthy Weight and Nutrition at Nationwide Children's Hospital* Oversees a comprehensive pediatric ob*sity center with activities that include advocacy, prevention, medical weight management and adolescent bariatric surgery* Directs the Primary Care Ob*sity Network (PCON) which provides ob*sity-related training, resources and community integration for 21 primary care practices in Central Ohio* Has particular interest in intervention research for pediatric ob*sity* Member of the National Academy of Sciences Roundtable on Ob*sity SolutionsRobin Hamre* Ob*sity prevention program team leader for the Centers for Disease Control and Prevention Madeline M. Joseph* Chief, Division of Pediatric Bariatrics University of Florida HealthDoug Lunsford* Lead Patient Principal Investigator, PCORnet Ob*sity Studymember of the Parent and Patient Leadership Team for the Healthy Weight Network* Co-founder of the Healthy Weight Community* Twitter Bio: Working to end childhood ob*sityEneida Mendonca* Biomedical Informatics expert, no link to ob*sity medicineMarc P. Michalsky * Novo Nordisk $13,576.47* Surgical Director for the Center for Healthy Weight and Nutrition at Nationwide Children's Hospital* Serves as a clinical investigator on several National Institutes of Health (NIH)-sponsored research initiatives examining outcomes following surgical weight reduction in the severely ob*se adolescent population.* Dr. Michalsky's team currently performs gastric sleeve surgery, gastric bypass surgery, and adjustable gastric banding on severely ob*se adolescentsNazrat Mirza (Rhythm Pharmaceuticals $526.50, Novo Nordisk $64.54)* Medical Director, IDEAL Pediatric Weight Management ClinicEduardo R. Ochoa * Merck $3,868.16* Principle investigator for the Children's Health Watch Little Rock site at Arkansas Children's HospitalMona Sharifi* Studies the effectiveness, cost-effectiveness, and implementation of novel primary care-based interventions for childhood ob*sity* Yale School of Medicine Ob*sity Research Working GroupAmanda E. Staiano* Pennington Biomedical Research Center. Assistant Professor, Pediatric Ob*sity and Health Behavior Lab* Studies the best ways to target children and adolescents who are most at-risk for ob*sity and chronic disease, tailoring physical activity interventions to help these children and adolescents achieve a healthy weightAshley E. Weedn * Novo Nordisk $64.52* During residency, she trained at the University of California at San Francisco in pediatric weight management* Her clinical and research interests are in childhood ob*sity. * She leads several pediatric ob*sity projects* Serves as the Medical Director of the OU pediatric multidisciplinary weight management clinic* Co-chairs the Ob*sity Special Interest Group of the Academic Pediatric Association* Serves as a Childhood Ob*sity Advisor for the American Academy of Pediatrics* Founded and co-chairs the Ob*sity Committee through the Oklahoma Chapter of the American Academy of Pediatrics* Works with pediatricians across the state to address childhood ob*sity, including development of toolkits and webinars for primary care providers on childhood ob*sity assessment and management.     Susan K. Flinn* Writer/editor for hireJeanne Lindros* Manager, Ob*sity Initiatives, American Academy of Pediatrics* Co-presenter: Virtual reality-based training for motivational interviewing around childhood ob*sity – are pediatricians “game”?Kymika Okechukwu* Senior Manager, Evidence-Based Medicine Initiatives  - American Academy of PediatricsStay tuned for Saturday's deep dive into the guidelines!Did you find this post helpful? You can subscribe for free to get future posts delivered direct to your inbox, or choose a paid subscription to support the newsletter and get special benefits! Click the Subscribe button below for details:Liked this piece? Share this piece:More research and resources:https://haeshealthsheets.com/resources/*Note on language: I use “fat” as a neutral descriptor as used by the fat activist community, I use “ob*se” and “overw*ight” to acknowledge that these are terms that were created to medicalize and pathologize fat bodies, with roots in racism and specifically anti-Blackness. Please read Sabrina Strings Fearing the Black Body – the Racial Origins of Fat Phobia and Da'Shaun Harrison Belly of the Beast: The Politics of Anti-Fatness as Anti-Blackness for more on this. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe

Surgical Director of the Cleveland Clinic Thyroid Center, Joyce Shin, MD, joins the Cancer Advances podcast to provide surgical insights on thyroid cancer. Listen as Dr. Shin discusses the benefits of multidisciplinary care, molecular profiling, and using a fine needle aspiration for thyroid nodules.

Dr. Douglas Johnston is the Chief of Cardiac Surgery, Northwestern Medicine and Professor of Surgery, Northwestern University Feinberg School of Medicine. Prior to that he was Vice Chairman of the Department of Thoracic and Cardiovascular Surgery, Program Director of the Thoracic Surgery Residency and Advanced Cardiothoracic Fellowships, Surgical Director of the Aortic Valve Center, and staff cardiac surgeon in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic. He completed his medical education at Harvard Medical School, where he was a Harvard National Scholar. Join us as we dive into the standardization of pathways and risk in healthcare, the importance of documentation and how innovation in healthcare drives patient outcomes.  

Brandon Hopkins, MD, Surgical Director of the Pediatric Center for Airway, Voice and Swallowing at Cleveland Clinic Children's, joins to discuss the spectrum of disorders that are treated in this center and the importance of coordination to achieve optimal outcomes. Dr. Hopkins also shares his thoughts on this year's American Academy of Otolaryngology – Head and Neck Surgery Annual Meeting that's taking place this week.

What is the value of completion lymph node dissection for patients with melanoma with sentinel-node metastases? The Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1) confirmed that SLNB is an important part in the treatment of patients with melanoma, but what needed to be done beyond that in managing the axilla?  Learning Objectives:  In this episode, we review perioperative chemotherapy regimens for locally advanced, resectable Gastric cancer, standard of care, and the future role for immunotherapy.  Hosts:  Adam Yopp, MD, FACS (@AdamYopp) is an Associate Professor of Surgery at the UT Southwestern Medical Center and is Chief of the Division of Surgical Oncology. He also serves as Surgical Director of the Liver Tumor Program. Caitlin Hester, MD (@CaitlinAHester) is a new Assistant Professor of Surgery at the University of Miami Gilbert Murimwa, MD (@GilbertZMurimwa) is a PGY-4 General Surgery Resident at the UT Southwestern Medical Center and a research fellow in the Hamon Center for Therapeutic Oncology Research. Papers Referenced in this Episode: Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma Morton et al. https://www.nejm.org/doi/full/10.1056/nejmoa1310460 Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma Faries et al. https://www.nejm.org/doi/full/10.1056/nejmoa1613210 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our Journal Review Series here: https://behindtheknife.org/podcast-series/journal-review/

Dr. Meera Gupta, Surgical Director of the Pediatric Kidney Program, joins us to discuss what to expect when your child needs an organ transplant and how to prepare for it.

Elizabeth G. Matzkin, MD, Surgical Director, Women's Musculoskeletal Health Chief of Women's Sports Medicine Associate Professor, Harvard Medical School Orthopaedic Surgery, Women's Health talks about  ACL injuries in women/Paige Bueckers

Dr. Ryan Rivosecchi, Pharm D Unit Based Clinical Pharmacist at UPMC and Dr. Pablo Sanchez, MD, PhD, FACS, Associate Professor of Cardiothoracic Surgery, Vice Chairmen, Benign Lung Diseases, Chief, Division of Lung Transplant and Lung Failure, Surgical Director of Lung Transplantation and ECMO, Director of Lung Transplant Research, and Director of Ex Vivo Lung Perfusion Program all within the Department of Cardiothoracic surgery at the University of Pittsburgh presents a lecture entitled "Anticoagulation Controversies and Future Directions in Extra corporeal Life Support".

*** FELLOWSHIP APPLICATION: https://docs.google.com/forms/d/e/1FAIpQLScxkGQTz-rh5OfPJBBdyvVZ4Pq2R8NWgBUOC1dt8VQHtvawhw/viewform *** How do you decide if a pancreatic head mass is resectable? Does vascular involvement matter? What impacts survival? Join the Surgical Oncology team as they dive into operative considerations when operating on borderline resectable and locally advanced pancreatic cancer. Break the nihilism and find out about the options available for patients with this dreaded malignancy. Learning Objectives:  In this episode, we review the various definitions for resectability in pancreatic cancer, as well as the various prognostic markers and decision points to consider when deciding which patients may benefit from an operation.  Hosts:  Adam Yopp, MD, FACS (@AdamYopp) is an Assistant Professor of Surgery at the UT Southwestern Medical Center and is Chief of the Division of Surgical Oncology. He also serves as Surgical Director of the Liver Tumor Program. Caitlin Hester, MD (@CaitlinAHester) is a 2nd Year Complex General Surgical Oncology Fellow at the MD Anderson Cancer Center. Gilbert Murimwa, MD (@GilbertZMurimwa) is a PGY-3 General Surgery Resident at the UT Southwestern Medical Center and a research fellow in the Hamon Center for Therapeutic Oncology Research. Please visit behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

Cristiano Quintini, MD, is the Program Director and Surgical Director of Cleveland Clinic's Liver Transplantation Program. In this episode of Butts and Guts, Dr. Quintini provides insight into what information is considered prior to a liver transplant and also discusses several strategies that be implemented when performing this type of surgery.

Suneel Kamath, MD, hematologist/medical oncologist and Siva Raja, MD, PhD, Surgical Director of the Center for Esophageal Diseases joins the Cancer Advances podcast to discuss the Esophageal Cancer Program. Listen as Dr. Kamath and Dr. Raja discuss this multidisciplinary program and the significant advancements that have been made over the last several years including less invasive therapies to treat esophageal cancer.

This episode is brought to you by ModMed. To learn more and see a demo of the #1 EHR system, EMA®, as well as Practice Management, Revenue Cycle Management, Analytics, Patient Engagement tools and more, visit modmed.com/orthopod. ModMed — it's about time. Eric L. Smith, M.D., FAOA is an Orthopedic Surgeon specializing in joint replacement, reconstructive surgery and revision surgery of the hip and knee at New England Baptist Hospital (NEBH). Dr. Smith is Chief of Arthroplasty at NEBH where he is involved in the clinical care of patients, research and teaching. Dr. Smith plays an active role in the Otto E. Aufranc Fellowship Program, where he provides advanced training to physicians in adult reconstructive surgery.  Topics include: -He's a remarkable guest and hear about his time growing up in California, including his love for hunting. He spent 10 years of active duty in the Army and was deployed to Afghanistan during Operation Enduring Freedom. We hear about how he received the Meritorious Service Medal and hear about his amazing history in his time of service. -He's part of an Orthopedic Surgeon duo and married to Dr. Elizabeth Matzkin. She is the Surgical Director, Women's Musculoskeletal Health and Chief of Women's Sports Medicine at Brigham and Women's Hospital. -Dr. Smith tells us what's new in the world of total knee replacement for patients. Find out more about Dr. Eric Smith here. This content in this Podcast is not approved for credit by CMEfy, however, you may reflect on how this Podcast applies to your day-to-day and engage to earn AMA PRA Category 1 Credit(s)™ via point-of-care learning activities by clicking below.

This week we were joined by Dr. Bill Kent, a cardiac surgeon at the University of Calgary, to talk about minimally invasive techniques in cardiac surgery. We were curious to learn from him where MIS techniques fit in an era of rapid evolution in cardiac surgery and particularly with the advent of new catheter based techniques. Dr. Kent had a number of important insights into the introduction of new technologies in surgery and the challenges associated with trying something new. Links: 1. Minimally invasive cardiac surgery and the importance of qualitative patient-centered metrics to guide innovations. https://www.sciencedirect.com/science/article/pii/S0022522319304507?via%3Dihub Bio: Dr. William Kent is a cardiac surgeon whose practice focuses on valve surgery and mechanical circulatory support. A Fellow of the Royal College of Surgeons of Canada and a member of the International Society for Minimally Invasive Cardiothoracic Surgery, the Society of Thoracic Surgeons, the Canadian Society of Cardiac Surgeons and the American College of Surgeons, Dr. Kent is particularly interested in minimally invasive mitral valve repair and aortic valve surgery, including aortic valve and root repair as well as the Ross procedure. Dr. Kent completed his undergraduate BA and MSc degrees in Neuroscience at Western University before obtaining his MD and FRCSC in General Surgery at Queen's University. He began his Cardiac Surgery training at the University of Alberta and then continued his residency training at the University of Calgary. Dr. Kent then completed a Fellowship in complex valve surgery, transplant and mechanical circulatory support at Northwestern University in Chicago, before joining the Libin Cardiovascular Institute in 2013. His current position is Clinical Assistant Professor in the Section of Cardiac Surgery. He leads the Minimally Invasive Valve Surgery Program and is Surgical Director of the Mechanical Circulatory Support Program.

In the first half of the show, Dr. Brian Lima, Surgical Director of Heart Transplantation and Mechanical Circulatory Support at Medical City Heart Hospital talks about the breakthrough new procedure first performed in December at the Hospital - the Donation After Cardiac Death (DCD) Transplant. As Dr. Lima describes, this procedure has been performed in very few locations in the US, after originating in Europe about 2 years ago. This was the first of its kind in Texas and once again the DFW Metroplex shows its brilliance as a center of medical excellence. Dr. Lima walks us through this procedure that literally revives a deceased heart in order to save another's life. We continue the theme with Dr. Tiffany Simms-Waldrip, Clinical Director of Stem Cell Transplant at Children's Health and Associate Professor at UT Southwestern Medical Center. She talks about a national database registry where people like you and I can register to donate stem cells that could possibly safe a child's life. The program is called "Be The Match" and is a wonderful way to know that your willingness to be a stem cell donor could give a child somewhere in the US another chance at life. The link for "Be The Match" is https://bethematch.org/ See acast.com/privacy for privacy and opt-out information.

In this episode we welcome back Dr. Jay Pal our new Surgical Director of MCS and Transplant.4:00 VAD's past & present 5:16 Patients & VAD 7:34 Future VADS 8:43 Artificial Heart 12:24 Surgery In's and Out's 14:35 Best Practices from Experience 17:00 Why Back to UW? 18:41 What's in the water at Duke? 20:10 Regional Partners 21:20 Partnering with Complexity in Care 24:16 Future of VADs 27:20 Thoughts on Allocation Changes 29:45 Nepal 37:32 Personal Benefits of Global Health Jay Pal, MD, PhD is the Surgical Director of the Heart Transplantation and Mechanical Circulatory Support programs in the Division of Cardiothoracic Surgery. His clinical and research interests lie in the surgical treatment of heart failure, including transplantation and mechanical circulatory support systems.He completed his general surgical residency at the UCSF Easy Bay program and his thoracic surgery residency at Duke University, where he developed an interest in heart failure. He has held faculty positions at the University of Texas Health Science Center San Antonio and the University of Colorado, as well as at the UW School of Medicine from 2013-2017.In addition, Dr. Pal has been coordinating an international medical effort in Nepal for several years and will continue this work in collaboration with the Department of Global Health at the University of Washington.He can be reached any time at jaydpal@uw.eduor you can use our digital front door: https://hipaa.jotform.com/uwheart/referralsThanks for listening!

On this episode I had a wonderful time interviewing Dr. Tea Nguyen. Dr. Tea is CEO & Surgical Director of a concierge podiatry practice on a mission to deliver innovate foot care through minimally invasive surgery and minimal insurance intrusion. We discuss her private practice model, knowing your value, and even dive into creative outlets. Instagram: @drtea_podiatrySquare site: https://drteapodiatry.square.site/  Welcome to She's a DPM. A podcast for women to share their experiences, knowledge, and insights on cultivating a life in, and outside, the field of Podiatric Medicine and Surgery.Contact me if there is a topic you'd like to hear more about, or if you know a kick ass Lady DPM who should be interviewed.Email: DrOexeman@gmail.com Instagram: @droexeman

Dr. Kermit goes on call with Dr. Brian Lima, Surgical Director of Heart Transplantation and Mechanical Circulatory Support at Medical City Dallas Heart Hospital in Dallas, Texas. They discuss Dr. Lima's book, "Heart to Beat," wherein he details his inspiring story. He is the son of Cuban immigrants who became a successful cardiothoracic surgeon. Dr. Lima's mantra is: success is not reserved for the smartest or most talented--it's earned by those who want it the most.

In this interview, Aimee Cruz, Founder of Moms on Maternity interviews Dr. Spencer Richlin about reproductive health. We talk pre-pregnancy planning, birth control, IVF, surrogacy, and how to know when it may be time to meet with a reproductive endocrinologist as well as how to find one that is right for you! Dr. Spencer Richlin is a board-certified Reproductive Endocrinologist with extensive reproductive surgical experience. He has been practicing at Reproductive Medicine Associates of Connecticut (RMACT) since 2004, where he is a partner and Surgical Director. Dr. Richlin Areas of Expertise - ·Fertility preservation ·Oncofertility ·General infertility and IVF ·Single mothers to be ·Egg freezing ·General genetics For more information: Moms on Maternity: https://www.momsonmaternity.com/​RMA of Connecticut: https://www.rmact.com/ Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

We pre-recorded today's conversation (via Zoom) during American Heart Month as part of our monthly Community Health series in partnership with Valley Health. We talked about heart disease and treatment options with Dr. Edward Kofsky, a cardiothoracic surgeon with Valley Health Cardiothoracic Surgeons. Dr. Kofsky is also the Surgical Director of the Coronary Heart Disease Clinical Council at Winchester Medical Center and the Surgical Director of the Valvular Heart Disease Clinical Council at Winchester Medical Center. Dr. Kofsky explained that heart disease is really a series of separate issues related to various aspects and elements of the heart itself. There are conditions related to the coronary arteries, which supply the heart muscle with blood. There are conditions related to the valves within the heart which prevent the blood from backing up into the wrong places within the heart or from backing up into the lungs. And there are conditions related to the actual muscle of the heart itself where the heart muscle may not function normally, or maybe diseased by any number of different kinds of processes, including infections and connective tissue disorders. Then there are problems related to the electrical conduction systems of the heart, the parts of the heart that provide the pacing to the heart and to the transformation of the electrical signals that cause the heart muscle to have its own unique beating which causes the heart muscle to work as a sort of a synchronized pump. In the second segment we discussed treatment options and the advancements in technology that have impacted recovery times and a patients ability to potentially avoid surgery completely. For more information, visit: https://www.valleyhealthlink.com/our-services/heart-vascular/

We highlight successful stories of Arab Americans and Arab Canadians who positively impact the community. Sponsored by Lipton Yellow Label.In this episode, we chat with Dr. Hassan Nemeh.Dr. Nemeh is the Head of Division of Cardiac Surgery, and Surgical Director of thoracic & Organ Transplant at Henry Ford Health System. Dr. Nemeh finished his residency at Wright State University, and fellowship in Heart Transplant at Cleveland Clinic. Dr. Nemeh performed the first double lung transplant in patient after vaping related injury. (https://www.henryford.com/news/2020/0...)Hosts: Anwar Jebran and Malek Abdulsamad.Music (Special Cover): https://www.basselmusic.com/Please visit our website, and follow up on social media and watch us on Youtube:https://linktr.ee/communiteainarabic

In today's episode, you will meet Dr. Thomas E. MacGillivray, MD. She is a national top cardiothoracic surgeon currently working at Houston Methodist Hospital, the DeBakey Heart & Vascular center as the Chief of Cardiac Surgery and Thoracic Transplant Surgery, as well as the Jimmy Howell Endowed Chair in Cardiovascular Surgery. Previously, he was Co-Director of the Thoracic Aortic Center and Surgical Director of the Adult Congenital Heart Disease Program at Massachusetts General Hospital in Boston. Dr. MacGillivray currently serves as the Society's Treasurer-Elect; he previously was Chair of the Council on Education and Member Service for the Society of Thoracic Surgery.To connect with Dr. Thomas E. MacGillivray, MD find his link below:Website:  https://www.houstonmethodist.org/heart-vascular/Thank you again for joining us today! If you know anybody that would benefit from this episode please share it with them and help spread the knowledge and motivation. Don't forget to show your support for the Powerful and Passionate Healthcare Professionals Podcast by writing a review on iTunes. Your feedback helps the success of our show and pushes us to continuously be better!ADDITIONAL RESOURCES Want to save 8+ hours of work and reboot your focus within 2 minutes so you can do the things you love to do? Yes, it's really possible -- and I'm going to prove it to you! I offer 3 FREE consultations per week. Book yours here before they run out! SabrinaRunbeck.com/Blueprint Want to instantly restore your energy and brighten your fatigued eyes in 2 minutes? Download your FREE audio exercises and discover them for yourself. This is just the tip of the iceberg, and I know you have a lot more questions that you want to get answered. Join us inside our private community for our weekly Ask Me Anything sessions and monthly networking with like-minded healthcare practitioners.